| Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) (NCT04924075) | Merck Sharp & Dohme LLC | 2021-08-12 |
| Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma (NCT04458935) | National Eye Institute (NEI) | 2020-07-02 |
| Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors (NCT04074135) | National Cancer Institute (NCI) | 2020-06-02 |
| Drivers of Hypoxia-induced Angiogenesis in Tumor Development (NCT03979833) | University of Copenhagen | 2019-06-14 |
| Familial Investigations of Childhood Cancer Predisposition (NCT03050268) | St. Jude Children's Research Hospital | 2017-04-06 |
| Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only) (NCT02108002) | National Institute of Neurological Disorders and Stroke (NINDS) | 2014-04-05 |
| MyVHL: Patient Natural History Study (NCT03749980) | Joshua Mann, MPH | 2012-01-01 |
| Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients (NCT02420067) | Marie Luise Bisgaard, MD | 2011-02-01 |
| Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease (NCT01015300) | Dartmouth-Hitchcock Medical Center | 2009-12-01 |
| Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease (NCT00970970) | University Medical Center Groningen | 2009-09-01 |
| Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (NCT00470977) | Manhattan Eye, Ear & Throat Hospital | 2007-05-01 |
| Use of Tracking Devices to Locate Abnormalities During Invasive Procedures (NCT00102544) | National Institutes of Health Clinical Center (CC) | 2005-02-23 |
| Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease (NCT00062166) | National Cancer Institute (NCI) | 2003-04-11 |
| Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584 (NCT00052013) | Novartis Pharmaceuticals | 2003-02-01 |
| Precision Medicine for Neurocutaneous Syndromes in Western China (NCT07327164) | West China Hospital | 2000-01-01 |
| Von Hippel-Lindau Disease Genetic Epidemiology Study (NCT00001803) | National Cancer Institute (NCI) | 1999-02-26 |